Table 1.
Baseline clinical characteristics of the patients included in the study.
| Variables | T1D Patients (n = 21) |
|---|---|
| Female/Male, n (%) | 13/8 (62/38) |
| Age, years (range) | 43.2 ± 15.1 (21–75) |
| Duration of diabetes, years (range) | 25.1 ± 13.6 (7–60) |
| BMI, kg/m2 (range) | 25.3 ± 4.9 (18–39) |
| Complications | |
| Retinopathy, n (%) | 8 (38) |
| Nephropathy, n (%) | 4 (19) |
| Coronary artery disease, n (%) | 1 (5) |
| Carotid macroangiopathy, n (%) | 2 (9.5) |
| Hypertension, n (%) | 8 (38) |
| HbA1c, % (range) | 8.08 ± 1.04 (6.3–10.6) |
| eGDR, mg/kg/min (range) | 7.28 ± 2.22 (1.7–10.4) |
| Severe hypoglycemic episode 1 last 12 months, n (%) | 8 (38) |
| CSII, n (%) | 18 (86) |
Data are expressed as mean ± standard deviation (range) or number (percentage). 1 Defined as ≥1 symptom of hypoglycemia with unconsciousness, blood glucose level < 54 mg/dL. Abbreviations: BMI, body mass index; CSII, continuous subcutaneous insulin infusion; eGDR, estimated glucose disposal rate; HbA1c, plasma glycated hemoglobin A1c; T1D, type 1 diabetes.